Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Apolipoprotein B levels and related factors in a rural white South African community--the CORIS study. Coronary Risk Factor Study.

Steyn K, Rossouw JE, Weight MJ, Fourie JM, Benadé AJ, Jooste PL, Chalton DO, Wolmarans P.

S Afr Med J. 1996 Apr;86(4):359-64.

PMID:
8693373
2.

The lipid and lipoprotein profile of the urban black South Africa population of the Cape Peninsula - the BRISK study.

Oelofse A, Jooste PL, Steyn K, Badenhorst CJ, Lombard C, Bourne L, Fourie J.

S Afr Med J. 1996 Feb;86(2):162-6.

PMID:
8619144
3.

The conjoint trait of low high-density lipoprotein cholesterol and high triglycerides in adolescent black and white males.

Morrison JA, Barton BA, Biro FM, Sprecher DL.

Metabolism. 1998 May;47(5):514-21.

PMID:
9591740
4.

Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.

Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, Vaduganathan M, Rao RS, Koschinsky M, Morrisett JD.

J Lipid Res. 2001 Apr;42(4):631-8.

5.

Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.

Westerveld HT, van Lennep JE, van Lennep HW, Liem AH, de Boo JA, van der Schouw YT, Erkelens DW.

Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1101-7.

6.

Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.

Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PW.

J Lipid Res. 1994 May;35(5):779-92.

7.

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

Circulation. 2005 Nov 29;112(22):3375-83.

9.
10.

Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.

Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J Jr.

Can J Cardiol. 1997 Mar;13(3):253-60.

PMID:
9117913
11.

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese.

Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB.

J Lipid Res. 2007 Nov;48(11):2499-505.

12.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W; Atherosclerosis Risk in Communities Study Group..

Circulation. 2001 Sep 4;104(10):1108-13.

13.

Impact of obesity on lipid profiles in middle-aged women.

Maksvytis A, Stakisaitis D.

Medicina (Kaunas). 2004;40(6):553-7.

15.

A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.

Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.

Chin Med J (Engl). 2004 Feb;117(2):163-7.

PMID:
14975195
16.
17.
18.

A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.

Winocour PH, Durrington PN, Bhatnagar D, Mbewu AD, Ishola M, Mackness M, Arrol S.

Diabetes Res Clin Pract. 1992 Dec;18(3):173-84.

PMID:
1289018
19.

Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.

Martinez-Hervas S, Real JT, Priego MA, Carratalá A, Sniderman AD, Carmena R, Ascaso JF.

Int J Clin Pract. 2013 Jan;67(1):81-8. doi: 10.1111/j.1742-1241.2012.02998.x.

PMID:
23241052
20.

Supplemental Content

Support Center